dpp-4 inhibitors and glp-1 agonists together Neuroprotection by dipeptidyl-peptidase-4 glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease Prescribing pearls: A guide to
Description
Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/AKT): Actions and defects in obesity and type II diabetes
Mazidi M, Rezaie P, Gao HK, Kengne AP
Investigation: H.D., J.T., P.D
Finally, the combination of a GLP-1 receptor agonist and amylin agonism by cagrilintide/semaglutide is currently under investigation (Table 1)
The relative positive areas were quantified with ImageJ (1.51j8, USA) 11
Understanding RAGE, the receptor for advanced glycation end products
